Skip to Content

Clinical Trials
Patient Portal

Loading component...

Loading component...

SCRI: MM165: Ph2 TECVAYLI in multiple myeloma patients ( IIT MM165)

Phase II Clinical Trial

64007957MMY2010/MM165: Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma (OPTec/OPTal)

Trial Number: 05972135

Trial Status: Call Proj Mgr

Learn more about this clinical trial.

About Us
Specialities & Services
Request Appointment
Careers
Contact Us
Media Center
Cancer Support Services
Careopolis

Find a Provider
Find a Location
Clinical Trials
Patient Portal
Patient Forms
Patient Resources
Patient Rights & Privacy
Insurance Information

© 2026 Texas Oncology. All rights reserved.|Privacy Notice|Terms of Use